New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase

J Cell Physiol. 2016 Aug;231(8):1784-95. doi: 10.1002/jcp.25283. Epub 2016 Feb 2.

Abstract

The aim of this paper is based on the use of a hyaluronic acid hydrogel of Quercetin tested alone and in combination to an inhibitor of Aurora Kinase type A and B (SNS-314) on human medullary and papillary thyroid cancer cells. Biological investigations were focused on the cellular uptake of the hydrogel, cell viability, antioxidant, and cytokines secretion studies. Quercetin delivered from hydrogel show a time and CD44 dependent interaction with both cell lines with significant anti-inflammatory effects. Combination of Quercetin and SNS-314 leads to a synergistic cytotoxic effect on medullary TT and papillary BCPAP cell lines with a significant reduction of the IC50 value. These results, highlights the importance of synergistic effect of the hyaluronic acid hydrogel of Quercetin with SNS-314 in the regulation of human thyroid cancer cell proliferation and emphasize the anti-tumor activity of these molecules. J. Cell. Physiol. 231: 1784-1795, 2016. © 2015 Wiley Periodicals, Inc.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / chemistry
  • Antineoplastic Combined Chemotherapy Protocols / metabolism
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Antioxidants / metabolism
  • Aurora Kinase A / genetics
  • Aurora Kinase A / metabolism*
  • Aurora Kinase B / antagonists & inhibitors*
  • Aurora Kinase B / metabolism
  • Carcinoma / drug therapy*
  • Carcinoma / enzymology
  • Carcinoma / pathology
  • Carcinoma, Neuroendocrine / drug therapy*
  • Carcinoma, Neuroendocrine / enzymology
  • Carcinoma, Neuroendocrine / pathology
  • Carcinoma, Papillary
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Chemistry, Pharmaceutical
  • Cytokines / metabolism
  • Dose-Response Relationship, Drug
  • Drug Carriers*
  • Drug Synergism
  • Humans
  • Hyaluronan Receptors / metabolism
  • Hyaluronic Acid / chemistry*
  • Hydrogels
  • Inhibitory Concentration 50
  • Phenylurea Compounds / chemistry
  • Phenylurea Compounds / metabolism
  • Phenylurea Compounds / pharmacology*
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / metabolism
  • Protein Kinase Inhibitors / pharmacology*
  • Quercetin / chemistry
  • Quercetin / metabolism
  • Quercetin / pharmacology*
  • Thiazoles / chemistry
  • Thiazoles / metabolism
  • Thiazoles / pharmacology*
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms / drug therapy*
  • Thyroid Neoplasms / enzymology
  • Thyroid Neoplasms / pathology
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • CD44 protein, human
  • Cytokines
  • Drug Carriers
  • Hyaluronan Receptors
  • Hydrogels
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • SNS 314
  • Thiazoles
  • Hyaluronic Acid
  • Quercetin
  • AURKA protein, human
  • AURKB protein, human
  • Aurora Kinase A
  • Aurora Kinase B

Supplementary concepts

  • Thyroid cancer, medullary